The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
ADHD and the Prefrontal Cortex
Open accessAbstract
Attention deficit/hyperactivity disorder (ADHD) is characterized by symptoms of inattention, impulsivity, and locomotor hyperactivity. Recent advances in neurobiology, imaging, and genetics have led to a greater understanding of the etiology and treatment of ADHD. Studies have found that ADHD is associated with weaker function and structure of prefrontal cortex (PFC) circuits, especially in the right hemisphere. The prefrontal association cortex plays a crucial role in regulating attention, behavior, and emotion, with the right hemisphere specialized for behavioral inhibition. The PFC is highly dependent on the correct neurochemical environment for proper function: noradrenergic stimulation of postsynaptic alpha-2A adrenoceptors and dopaminergic stimulation of D1 receptors is necessary for optimal prefrontal function. ADHD is associated with genetic changes that weaken catecholamine signaling and, in some patients, with slowed PFC maturation. Effective pharmacologic treatments for ADHD all enhance catecholamine signaling in the PFC and strengthen its regulation of attention and behavior. Recent animal studies show that therapeutic doses of stimulant medications preferentially increase norepinephrine and, to a lesser extent, dopamine, in the PFC. These doses reduce locomotor activity and improve PFC regulation of attention and behavior through enhanced catecholamine stimulation of alpha-2A and D1 receptors. These findings in animals are consistent with improved PFC function in normal human subjects and, more prominently, in patients with ADHD. Thus, a highly cohesive story is emerging regarding the etiology and treatment of ADHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of catecholaminergic innervation underlies the most important ADHD symptoms [381].”
From Development of prefrontal cortex (2022) · cites this paper as [381]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alteration of glutamate/GABA equilibrium has been related to a diminished capability to focus on demanding tasks [98] and to result in DA dysregulation, causing inhibition of defective pyramidal neurons and a decrease shift in excitation towards tasks regulated in the PFC [99, 100].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [99]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Inhibition and the right inferior frontal cortex
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.02.010 · Cited by 3,197
Mesulam, M. (1998) · Brain · doi:10.1093/brain/121.6.1013 · Cited by 3,072
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
A cortical network for directed attention and unilateral neglect
Mesulam, M. ‐. (1981) · Annals of Neurology · doi:10.1002/ana.410100402 · Cited by 2,498
Top-Down Versus Bottom-Up Control of Attention in the Prefrontal and Posterior Parietal Cortices
Buschman, T. J., & Miller, E. K. (2007) · Science · doi:10.1126/science.1138071 · Cited by 2,380
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357
Effects of parietal injury on covert orienting of attention
Posner, M., Walker, J., Friedrich, F., & Rafal, R. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-07-01863.1984 · Cited by 2,191
Tol, H. H. M. V., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P. M., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,015
Basal ganglia and cerebellar loops: motor and cognitive circuits
Middleton, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00040-5 · Cited by 1,940
Research works printed but not linked: 11
- [1]Solanto MV Solanto MV Arnsten AFT Castellanos FX Attention-Deficit/Hyperactivity Disorder: Clinical features Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 New York Oxford University Press 3 30
- [3]Stuss DT Knight RT Principles of Frontal Lobe Function 2002 New York Oxford University Press
- [26]DSM I. Diagnostic and statistical manual of mental disorders 4th edition American Psychiatric Association
- [82]Arnsten AFT Manji HK Mania: A rational neurobiology Future Neurology 2008 3 in press.
- [90]Arnsten AFT Steere JC Hunt RD The contribution of alpha-2 noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance to Attention Deficit Hyperactivity Disorder Arch Gen Psychiatry 1996 53 448 455 8624188
- [95]Seidman LJ Valera EM Makris N Structural brain imaging of attention-deficit/hyperactivity disorder Biol Psychiatry 2005 57 1263 1272 15949998
- [112]Comings DE Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders Ann N Y Acad Sci 2001 931 50 83 11462757
- [122]van Dyck CH Quinlan DM Cretella L Staley JK Malison RT Baldwin RM Striatal dopamine transporter availability with [123I]β-CIT SPECT is unaltered in adult Attention Deficit Hyperactivity Disorder Am. J. Psychiatry 2002 159 309 312 11823278
- [149]Engberg G Eriksson E Effects of alpha-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats Naunyn-Schmiedebergs Arch. Pharmacol 1991 343 472 477 1652697
- [150]Scahill L Chappell PB Kim YS Schultz RT Katsovich L Shepherd E Guanfacine in the treatment of children with tic disorders and ADHD: A placebo-controlled study Amer. J. Psychiatry 2001 158 1067 1074 11431228
- [156]Group TTsSS Treatment of ADHD in children with tics: a randomized controlled trial Neurology 2002 58 527 536 11865128
Cited by
Sorted by citations
Arnsten, A. F. T., & Rubia, K. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.008 · Cited by 568
Self-citationRubia, K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.023 · Cited by 440
Development of prefrontal cortex
Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378
“Attention deficit/hyperactivity disorder (ADHD) is a NDD characterized by signs of inattention, impulsivity, and hyperactivity [380, 381].”
BackgroundPharmacotherapy of obesity: available medications and drugs under investigation.
Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248
Choi, W.-S., Woo, Y. S., Wang, S.-M., Lim, H. K., & Bahk, W.-M. (2022) · PLOS ONE · doi:10.1371/journal.pone.0277175 · Cited by 221
Perry, J. L., Joseph, J. E., Jiang, Y., Zimmerman, R. S., Kelly, T. H., Darna, M., Huettl, P., Dwoskin, L. P., & Bardo, M. T. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.09.001 · Cited by 180
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147
Neurobiology of Attention Deficit/Hyperactivity Disorder
Purper‐Ouakil, D., Ramoz, N., Lepagnol-Bestel, A.-M., Gorwood, P. A. P. M., & Simonneau, M. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212b40f · Cited by 160
Sonuga-Barke, E. J. S., Wiersema, J. R., van der Meere, J. J., & Roeyers, H. (2010) · Neuropsychology Review · doi:10.1007/s11065-009-9115-0 · Cited by 142
Hulvershorn, L. A., Mennes, M., Castellanos, F. X., Di Martino, A., Milham, M. P., Hummer, T. A., & Roy, A. K. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.012 · Cited by 138
Liao, C., Laporte, A. D., Spiegelman, D., Akçimen, F., Joober, R., Dion, P. A., & Rouleau, G. A. (2019) · Nature Communications · doi:10.1038/s41467-019-12450-9 · Cited by 130
Zheng, F., Gao, P., He, M., Li, M., Wang, C., Zeng, Q., Zhou, Z., Yu, Z., & Zhang, L. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1022 · Cited by 113
Cerebellar-Subcortical-Cortical Systems as Modulators of Cognitive Functions
Clark, S., Semmel, E. S., Aleksonis, H. A., Steinberg, S. N., & King, T. Z. (2021) · Neuropsychology Review · doi:10.1007/s11065-020-09465-1 · Cited by 119
Karalunas, S. L., Gustafsson, H. C., Dieckmann, N. F., Tipsord, J., Mitchell, S. H., & Nigg, J. T. (2017) · Journal of Abnormal Psychology · doi:10.1037/abn0000292 · Cited by 104
Dougherty, C. C., Evans, D. W., Myers, S. M., Moore, G. J., & Michael, A. M. (2016) · Neuropsychology Review · doi:10.1007/s11065-015-9300-2 · Cited by 104
The role of prefrontal catecholamines in attention and working memory
Clark, K., & Noudoost, B. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00033 · Cited by 113
Yu, C., Garcia-Olivares, J., Candler, S., Schwabe, S., & Maletic, V. (2020) · Journal of Experimental Pharmacology · doi:10.2147/jep.s256586 · Cited by 96
New onset executive function difficulties at menopause: a possible role for lisdexamfetamine
Epperson, C. N., Shanmugan, S., Kim, D. R., Mathews, S., Czarkowski, K. A., Bradley, J., Appleby, D. H., Iannelli, C., Sammel, M. D., & Brown, T. E. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3953-7 · Cited by 90
Artificial food dyes and attention deficit hyperactivity disorder
Kanarek, R. B. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00385.x · Cited by 84
An, L., Cao, X.-H., Cao, Q.-J., Sun, L., Yang, L., Zou, Q.-H., Katya, R., Zang, Y.-F., & Wang, Y.-F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.27 · Cited by 88
Heart Rate Variability in Children with Attention-Deficit/Hyperactivity Disorder: A Pilot Study
Rukmani, M. R., Seshadri, S. P., Thennarasu, K., Raju, T. R., & Sathyaprabha, T. N. (2016) · Annals of Neurosciences · doi:10.1159/000443574 · Cited by 73
Quintero, J., Gutiérrez-Casares, J. R., & Álamo, C. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00392-2 · Cited by 70
“However, the MPH effects on these signalling pathways were totally inhibited using ADRD1B blockers, showing that ADRD1B mediates the phosphorylation of PKA signalling through MPH in the PFC [143].”
BackgroundInfluentialReducing substance use during adolescence: a translational framework for prevention
Stanis, J. J., & Andersen, S. L. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3393-1 · Cited by 75
Adult ADHD: Underdiagnosis of a Treatable Condition
Rivas-Vazquez, R. A., Diaz, S. G., Visser, M. M., & Rivas-Vazquez, A. A. (2023) · Journal of Health Service Psychology · doi:10.1007/s42843-023-00077-w · Cited by 85
Oh, S., Choi, J., Han, D. H., & Kim, E. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02174-z · Cited by 63
Kozłowska, A., Wojtacha, P., Równiak, M., Kolenkiewicz, M., & Huang, A. C. W. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5180-0 · Cited by 64
Knecht, C., de Alvaro, R., Martı́nez-Raga, J., & Balanzá‐Martínez, V. (2014) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2015-5007 · Cited by 73
Boczek, T., Mackiewicz, J., Sobolczyk, M., Wawrzyniak, J., Lisek, M., Ferenc, B., Guo, F., & Żylińska, L. (2021) · Cells · doi:10.3390/cells10051228 · Cited by 63
Abu‐Elfotuh, K., Abdel-Sattar, S. A., Abbas, A. N., Mahran, Y. F., Alshanwani, A. R., Hamdan, A. M., Atwa, A. M., Reda, E., Ahmed, Y. M., Zaghlool, S. S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113799 · Cited by 62
Working for the future: parentally deprived Nigerian Children have enhanced working memory ability
Nweze, T., Nwoke, M. B., Nwufo, J. I., Aniekwu, R. I., & Lange, F. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13241 · Cited by 58
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Huß, M., Chen, W., & Ludolph, A. G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0336-0 · Cited by 60
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status
Findling, R. L., Candler, S. A., Nasser, A. F., Schwabe, S., Yu, C., Garcia-Olivares, J., O’Neal, W., & Newcorn, J. H. (2021) · CNS Drugs · doi:10.1007/s40263-021-00825-w · Cited by 55
Beaudin, S. A., Strupp, B. J., Strawderman, M. S., & Smith, D. R. (2016) · Environmental Health Perspectives · doi:10.1289/ehp258 · Cited by 56
Kollins, S. H., López, F. A., Vince, B. D., Turnbow, J. M., Farrand, K., Lyne, A., Wigal, S. B., & Roth, T. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0064 · Cited by 53
Gillett, G., Watson, G., Saunders, K., & McGowan, N. M. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.043 · Cited by 55
Genesis and Maintenance of Attentional Biases: The Role of the Locus Coeruleus-Noradrenaline System
Ehlers, M. R., & Todd, R. M. (2017) · Neural Plasticity · doi:10.1155/2017/6817349 · Cited by 50
Novel pharmacological targets for GABAergic dysfunction in ADHD
Ferranti, A. S., Luessen, D. J., & Niswender, C. M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109897 · Cited by 48
The impact of acute tryptophan depletion on attentional performance in adult patients with ADHD
Mette, C., Zimmermann, M., Grabemann, M., Abdel‐Hamid, M., UEKERMANN, J., Biskup, C. S., Wiltfang, J., Zepf, F. D., & Kis, B. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12090 · Cited by 47
Who says this is a modern disorder? The early history of attention deficit hyperactivity disorder
Martı́nez-Raga, J. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i4.379 · Cited by 65
Spatial Attention, Feature-Based Attention, and Saccades: Three Sides of One Coin?
Mazer, J. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.014 · Cited by 40
Loh, H. W., Ooi, C. P., Oh, S. L., Barua, P. D., Tan, Y. R., Acharya, U. R., & Fung, D. S. S. (2023) · Cognitive Neurodynamics · doi:10.1007/s11571-023-10028-2 · Cited by 44
Schmeichel, B. E., Zemlan, F. P., & Berridge, C. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.005 · Cited by 40
Risk of ADHD After Multiple Exposures to General Anesthesia: A Nationwide Retrospective Cohort Study
Tsai, C.-J., Lee, C. T., Liang, S. H., Tsai, P.-J., Chen, V. C., & Gossop, M. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715587094 · Cited by 38
Umehara, M., Ago, Y., Fujita, K., Hiramatsu, N., Takuma, K., & Matsuda, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.033 · Cited by 37
Morris, L. S., To, B., Baek, K., Chang-Webb, Y. C., Mitchell, S., Strelchuk, D., Mikheenko, Y., Phillips, W., Zandi, M. S., Jenaway, A., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.08.007 · Cited by 41
Conley, T. E., Beaudin, S. A., Lasley, S. M., Fornal, C. A., Hartman, J., Uribe, W., Khan, T., Strupp, B. J., & Smith, D. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14934 · Cited by 38
Bubenzer‐Busch, S., Herpertz‐Dahlmann, B., Kuzmanovic, B., Gaber, T. J., Helmbold, K., Ullisch, M. G., Baurmann, D., Eickhoff, S. B., Fink, G. R., & Zepf, F. D. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12475 · Cited by 35
Corominas, M., Ramos‐Quiroga, J. A., Ferrer, M., Sáez‐Francàs, N., Gloria Palomar, A., Bosch, R., & Casas, M. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0075-5 · Cited by 40
Bayless, D. W., Darling, J. S., & Daniel, J. M. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.10.003 · Cited by 34
Lasley, S. M., Fornal, C. A., Mandal, S., Strupp, B. J., Beaudin, S. A., & Smith, D. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz208 · Cited by 34
ADHD Identification using Convolutional Neural Network with Seed-based Approach for fMRI Data
Ariyarathne, G., Silva, S. D., Dayarathna, S., Meedeniya, D., & Jayarathne, S. (2020) · International Conference on Software and Computer Applications (ICSCA) · doi:10.1145/3384544.3384552 · Cited by 33
Albayrak, Ö., Albrecht, B., Scherag, S., Barth, N., Hinney, A., & Hebebrand, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.023 · Cited by 31
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_33-1 · Cited by 33
Challenges in the Transition of Care for Adolescents With Attention-Deficit/Hyperactivity Disorder
Robb, A. S., & Findling, R. L. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2685 · Cited by 29
Kawaura, K., Karasawa, J.-I., Chaki, S., & Hikichi, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.044 · Cited by 29
Smith, D. R., & Strupp, B. J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01345-9 · Cited by 28
Lisdexamfetamine: A pharmacokinetic review
Comiran, E., Kessler, F. H., Fröehlich, P. E., & Limberger, R. P. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.04.026 · Cited by 31
Song, I. G., Kim, H., Cho, Y.-M., Lim, Y., Moon, D.-S., Shin, S. H., Kim, E., Park, J., Shin, J. E., Han, J. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06094-x · Cited by 28
Matsuo, Y., Watanabe, M., Taniike, M., Mohri, I., Kobashi, S., Tachibana, M., Kobayashi, Y., & Kitamura, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125573 · Cited by 26
Dimitrov, L. V., Kaminski, J. W., Holbrook, J. R., Bitsko, R. H., Yeh, M., Courtney, J. G., O’Masta, B., Maher, B. S., Cerles, A. A., McGowan, K., et al. (2023) · Prevention Science · doi:10.1007/s11121-023-01601-6 · Cited by 27
Fikke, L. T., Melinder, A. M. D., & Landrø, N. I. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2283 · Cited by 28
Andrzejewski, M. E., Spencer, R. C., Harris, R. L., Feit, E. C., McKee, B. L., & Berridge, C. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.018 · Cited by 24
Caballero-Puntiverio, M., Lerdrup, L., Arvastson, L., Aznar, S., & Andreasen, J. T. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109823 · Cited by 23
Johnstone, S. J., Parrish, L., Jiang, H., Zhang, D., Williams, V., & Sun, L. (2021) · Biological Psychology · doi:10.1016/j.biopsycho.2021.108080 · Cited by 23
Amengual, J. L., Bello, F. D., Hamed, S. B., & Hamed, S. B. (2022) · Nature Communications · doi:10.1038/s41467-022-32385-y · Cited by 20
Hayton, S. J., Olmstead, M. C., & Dumont, É. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023885 · Cited by 21
Attention Networks in ADHD Adults after Working Memory Training with a Dual n-Back Task
Dotare, M., Bader, M., Mesrobian, S. K., Asai, Y., Villa, A. E. P., & Lintas, A. (2020) · Brain Sciences · doi:10.3390/brainsci10100715 · Cited by 21
Sears, C. G., Sears, L. L., & Zierold, K. M. (2020) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2020.106855 · Cited by 21
Romero-García, R., Hook, R. W., Tiego, J., Bethlehem, R. A. I., Goodyer, I. M., Jones, P. B., Dolan, R. J., Grant, J. E., Bullmore, E. T., Yücel, M., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00848-9 · Cited by 21
Korte, S. M., Prins, J., van den Bergh, F. S., Oosting, R. S., Dupree, R., Korte-Bouws, G. A. H., Westphal, K. G. C., Olivier, B., Denys, D. A. J. P., Garland, A., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.024 · Cited by 19
Pongpitakdamrong, A., Chirdkiatgumchai, V., Ruangdaraganon, N., Roongpraiwan, R., Sirachainan, N., Soongprasit, M., & Udomsubpayakul, U. (2021) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000993 · Cited by 19
Zepf, F. D., Bubenzer‐Busch, S., Runions, K., Rao, P., Wong, J. W. Y., Mahfouda, S., Morandini, H. A. E., Stewart, R. M., Moore, J. K., Biskup, C. S., et al. (2017) · Brain and Cognition · doi:10.1016/j.bandc.2017.10.005 · Cited by 20
Batten, S. R., Hartle, A. E., Barbosa, L. S., Hadj-Amar, B., Bang, D., Melville, N., Twomey, T., White, J. P., Torres, A. S., Celaya, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115162 · Cited by 21
Stimulant medications affect arousal and reward, not attention networks
Kay, B. P., Wheelock, M. D., Siegel, J. S., Raut, R. V., Chauvin, R. J., Metoki, A., Rajesh, A., Eck, A., Pollaro, J., Wang, A., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.039 · Cited by 25
Peña, I. D., Shen, G., & Shi, W. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173826 · Cited by 18
Behavioral and Psychiatric Disorders in Syndromic Autism
Genovese, A., & Butler, M. G. (2024) · Brain Sciences · doi:10.3390/brainsci14040343 · Cited by 22
Methylphenidate alleviates manganese-induced impulsivity but not distractibility
Beaudin, S. A., Strupp, B. J., Uribe, W., Ysais, L., Strawderman, M. S., & Smith, D. R. (2017) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.03.005 · Cited by 17
Martínez-Raga, J., Knecht, C., & de Alvaro, R. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65735 · Cited by 15
NR4A2: Effects of an “Orphan” Receptor on Sustained Attention in a Schizophrenic Population
Ancín, I., Cabranes, J. A., Vázquez-Álvarez, B., Santos, J. L., Sánchez‐Morla, E. M., Alaerts, M., Del‐Favero, J., & Barabash, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr176 · Cited by 17
Hawkins, R. D. (2013) · Learning & Memory · doi:10.1101/lm.031237.113 · Cited by 17
The use of attention-deficit hyperactivity disorder medications in cardiac disease
Topriceanu, C., Moon, J., Captur, G., & Perera, B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1020961 · Cited by 21
Agoalikum, E., Klugah‐Brown, B., Wu, H., Hu, P., Jing, J., & Biswal, B. B. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1076873 · Cited by 17
Luking, K. R., Jirsaraie, R. J., Tillman, R., Luby, J. L., Barch, D. M., & Sotiras, A. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.06.013 · Cited by 16
Umehara, M., Ago, Y., Kawanai, T., Fujita, K., Hiramatsu, N., Takuma, K., & Matsuda, T. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283633648 · Cited by 15
Kubas, H. A., Backenson, E. M., Wilcox, G., Piercy, J. C., & Hale, J. B. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2592 · Cited by 14
Salehzadeh, S. A., Mohammadian, A., & Salimi, F. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.101884 · Cited by 14
Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
Boberg, E., Iacobaeus, E., Greenfield, M. S., Wang, Y., Msghina, M., & Blanc, K. L. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01539-9 · Cited by 14
Díaz, F. C., Kramar, C. P., Hernandez, M. A., & Medina, J. H. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00209 · Cited by 16
Hermes, G., Hyman, S. M., Fogelman, N., Kosten, T. R., & Sinha, R. (2019) · American Journal on Addictions · doi:10.1111/ajad.12942 · Cited by 14
An, D., You, Y., Ma, Q., Xu, Z., Liu, Z., Liao, R., Chen, H., Wang, Y., Wang, Y., Dai, H., et al. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.002 · Cited by 13
Schildroth, S., Friedman, A., White, R. F., Kordas, K., Placidi, D., Bauer, J. A., Webster, T. F., Coull, B. A., Cagna, G., Wright, R. O., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115457 · Cited by 12
Meisinger, C., & Freuer, D. (2023) · BMJ Mental Health · doi:10.1136/bmjment-2022-300642 · Cited by 12
Chai, Y., Chimelis-Santiago, J. R., Bixler, K., Aalsma, M. C., Yu, M., & Hulvershorn, L. A. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102789 · Cited by 13
Single cell spatial biology over developmental time can decipher pediatric brain pathologies
Nussinov, R., Yavuz, B. R., & Jang, H. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106597 · Cited by 12
Ryan, J. E., Fruchtman, M., Sparr‐Jaswa, A., Knehans, A. C., & Worster, B. K. (2024) · Developmental Psychobiology · doi:10.1002/dev.22540 · Cited by 11
Huang, H.-C., Wu, L. S., Yu, S.-C., Wu, B., Lua, A. C., Lee, S.-M., & Liu, C. (2018) · Psychiatry Investigation · doi:10.30773/pi.2017.07.24 · Cited by 11
Frankowska, M., Miszkiel, J., Pomierny-Chamioło, L., Pomierny, B., Giannotti, G., Suder, A., & Filip, M. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118821113 · Cited by 12
BrainNET: Inference of Brain Network Topology Using Machine Learning
Murugesan, G. K., Yogananda, C. G. B., Nalawade, S. S., Davenport, E. M., Wagner, B. C., Kim, W. H., & Maldjian, J. A. (2020) · Brain Connectivity · doi:10.1089/brain.2020.0745 · Cited by 11
Schneider, H., Riederle, J., & Seuss, S. (2021) · Artificial intelligence · doi:10.5772/intechopen.97938 · Cited by 11
Faraone, S. V., Ward, C. L., Boucher, M., Elbekai, R., & Brunner, E. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106275 · Cited by 10
Metadata
- Authors
- Arnsten, A. F. T.
- Affiliations
- Yale University (US)
- Corresponding author
- Arnsten, Amy F.T.
- ORCID
- Arnsten, Amy F.T.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 154
- Issue
- 5
- Pages
- I-S43
- ISSN
- 0022-3476 (ISSN-L)
- PMC
- PMC2894421
- OpenAlex
- W11706560
- Cited by
- 220
- References
- 5
- Citations by year
- 2026: 30 · 2025: 31 · 2024: 23 · 2023: 23 · 2022: 12 · 2021: 13 · 2020: 11 · 2019: 10 · 2018: 3 · 2017: 7 · 2016: 5 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 10
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R37AG006036)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, prefrontal cortex, right hemisphere, behavioral inhibition, catecholamine signaling, dopamine D1 receptor, prefrontal cortex maturation, stimulant medication, norepinephrine, dopamine, ADHD etiology, ADHD treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review